(Q77948519)
Statements
Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells (English)
Christian Meyer zum Büschenfelde
Christine Hermann
Burkhard Schmidt
Christian Peschel